Press Release - European Investment Bank to support increased vaccine production in South Africa by Biovac

The European Investment Bank, in close cooperation with the European Union, is planning to support large-scale investment by South Africa’s specialist human vaccine manufacturer Biovac to increase development and manufacturing of vaccines and enable a quicker response to future pandemics.

Press contacts

EIB: Richard Willis, r.willis@eib.org, tel.: +352 43 79 82155 / Mobile:  +352 621 55 57 58

Website: www.eib.org/press - Press Office: +352 4379 21000 – press@eib.org

Biovac: Zaiem Fortune, zaiemf@biovac.co.za/ media@biovac.co.za, tel: +2721 5145000/

Website:www@biovac.co.za